FLAGSTAFF, Ariz. & AMSTERDAM--(BUSINESS WIRE)--(European Society for Vascular Surgery Annual Meeting)—W. L. Gore & Associates (Gore) today announced the first clinical uses of the GORE® C3 Delivery System to deploy the GORE EXCLUDER AAA Endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA). The GORE C3 Delivery System provides surgeons and interventionalists with added deployment control with the ability to reposition the GORE EXCLUDER Device, increased confidence while treating challenging anatomies, and cannulation options with the ability to bring the contralateral gate to the contralateral guidewire.
